Trending
- FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer
- FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival
- Pancreatic adenocarcinoma comprises six universally coexisting cell states
- Wrexham hospital trials breath test for pancreatic cancer
- Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer
- Rewriting the Prescription: Can Exercise Optimize Treatment Outcomes in Oncology?
- Adaptive Planning Trial Aims to Improve Radiosurgery Precision in Brain Metastases
- Decitabine suppresses triple-negative breast cancer by disrupting DNMT1 liquid-liquid phase separation and synergizes with G9a inhibition
Wednesday, August 26